Nrgene Technologies Ltd (NRGN) fair value: what the stock is really worth
As of Sep 30, 2026: fair value of Nrgene Technologies Ltd ILS 1.17, price ILS 0.83, upside +41.0%, quality 55 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.
How to read this chart
60‑month range 0.8120 ILA – 18.33 ILA · fair‑value band 1.11 ILA – 1.25 ILA · the 0.8300 ILA price screens below the 1.17 ILA fair value. Dashed = 300-day average. As of Oct 4, 2026.
Follow Nrgene Technologies in your weekly email
Every Wednesday you see whether Nrgene Technologies is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
NRGene Technologies Ltd operates as a research and development company focusing on intellectual property-intensive technological products in the field of AgTech in North America, Europe, the Middle East, Africa, Asia Pacific, and internationally.
Show more
NRGene Technologies Ltd operates as a research and development company focusing on intellectual property-intensive technological products in the field of AgTech in North America, Europe, the Middle East, Africa, Asia Pacific, and internationally. It develops and commercializes plant varieties, traits, and animals based on artificial intelligence (AI) technology and software tools for analyzing genetic information. The company also offers Supree semi-dried cherry tomatoes; clubroot-resistant canola; and black soldier fly as an alternative to animal-based protein. Its technology portfolio includes DeNovoMAGIC, a de novo assembly solution that assembles genomes. NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.
Stock analysis
Nrgene Technologies Ltd (NRGN) currently trades at 0.8300 ILA, while our model-based Fair Value estimate is 1.17 ILA, implying the stock looks roughly 29.1% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of 1.19 ILA per share, and 6 of the 7 models we run sit above the 0.8300 ILA price.
Bear case: the Asset-Based group reads lowest at 0.6600 ILA, and 1 of the 7 models stay below the price. Evidence for this calculation is low.
Scenario range: 1.11 ILA (bear) to 1.25 ILA (bull), the price of 0.8300 ILA sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 55/100 (solid quality), in the Technology sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Nrgene Technologies Ltd reported revenue of $3.2M in FY2025 versus $4.5M in FY2021, a compound −8.2%/yr. Reported net income was −$1.5M in FY2025.
Key figures
Market cap 10.9M ILA · P/S ratio 3.76 · EPS (TTM) −0.3400 ILA · Net margin −47.4% · Return on equity −74.9% · Return on assets (EBIT) −36.7% · Operating margin −537% · Revenue (TTM) $2.9M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).
What moves the price
The share trades about 72% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at −8% fair-value upside, at 41%, NRGN screens cheaper than that median.
Fair Value models
Bear 1.11 ILAFair Value 1.17 ILABull 1.25 ILA
Price 0.8300 ILA · Upside +41.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.18/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+145.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−14.7%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−11.3%
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−24.4% (2020) → −49.5% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
Little optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
less than -40 %
Yearly growth needed for the next five years to justify today's price.
Compare Nrgene Technologies Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Software - Application · 669 stocks
Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score55 · Below median
Fair Value upside+41.0% · Top 25%
Profitability
Return on assets−16.7% · Bottom 25%
Net margin (TTM)−55.5% · Bottom 25%
Growth and dividend
Revenue growth−38.0% · Bottom 25%
Valuation Multiplesvs Software - Application median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Nrgene Technologies Ltd (NRGN) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of 1.17 ILA versus a price of 0.8300 ILA, about +41% upside (undervalued).
What is the fair value of NRGN?
Our model-based fair value for Nrgene Technologies Ltd is 1.17 ILA (as of Oct 4, 2026), built from audited fundamentals. The current price: 0.8300 ILA.
What is the quality score of NRGN?
Nrgene Technologies Ltd has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nrgene Technologies Ltd (NRGN)?
Our model-based price target is the fair value of 1.17 ILA (as of Oct 4, 2026) from 7 valuation models. Cautious scenario 1.11 ILA, optimistic scenario 1.25 ILA. It is a calculation from audited fundamentals, not an analyst target.
What is the Nrgene Technologies Ltd stock forecast for 2026?
Our models put fair value at 1.17 ILA, about +41% upside versus a price of 0.8300 ILA (undervalued). Cautious scenario 1.11 ILA, optimistic scenario 1.25 ILA. The calculation is refreshed regularly with new filings.
What is the revenue of Nrgene Technologies Ltd (NRGN)?
Nrgene Technologies Ltd reported trailing-twelve-month revenue of about $2.9M (latest available figure, as of Oct 4, 2026).
What growth is priced into Nrgene Technologies Ltd (NRGN)?
For today's price to be fair in a discounted-cash-flow model, Nrgene Technologies Ltd would have to grow free cash flow by less than minus 40 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -14.7 % per year. As of Oct 4, 2026.
What discount rate (WACC) does the fair value of NRGN use?
Our models discount Nrgene Technologies Ltd at 11.6 %: a base by market capitalisation (nano), country premium for Israel. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Nrgene Technologies Ltd that is less than minus 40 % per year a year over ten years, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has Nrgene Technologies Ltd (NRGN) delivered so far?
Over the past 5 years revenue at Nrgene Technologies Ltd grew -14.7 % a year. The price currently implies less than minus 40 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Nrgene Technologies Ltd (NRGN) growing?
The median revenue growth in the sector is +10.4 % a year. That is the yardstick for the growth priced into Nrgene Technologies Ltd (less than minus 40 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Nrgene Technologies Ltd (NRGN)?
The free-cash-flow yield on the price is 2.02 %: that much free cash flow Nrgene Technologies Ltd produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Nrgene Technologies Ltd (NRGN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nrgene Technologies Ltd it is 1.17 ILA per share (as of Oct 4, 2026), against a price of 0.8300 ILA. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is Nrgene Technologies Ltd stock overvalued or undervalued in 2026?
As of Oct 4, 2026, NRGN trades below its calculated fair value: price 0.8300 ILA, fair value 1.17 ILA, a gap of about +41% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NRGN?
No. The price is what the market pays today (0.8300 ILA); the fair value is what the company's own numbers justify (1.17 ILA). For Nrgene Technologies Ltd the two are 0.3400 ILA per share apart. That gap is exactly why we show both numbers side by side.
How much is Nrgene Technologies Ltd worth?
The market values Nrgene Technologies Ltd at about 10.9M ILA (market capitalisation, as of Oct 4, 2026). Per share that is 0.8300 ILA; our models calculate a fair value of 1.17 ILA per share.
What do the bullish and bearish scenarios say about NRGN?
Our models span a range for Nrgene Technologies Ltd: cautious scenario 1.11 ILA, base 1.17 ILA, optimistic 1.25 ILA per share (as of Oct 4, 2026, price 0.8300 ILA). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Nrgene Technologies Ltd (NRGN)?
Balance-sheet figures for Nrgene Technologies Ltd (as of Oct 4, 2026): return on equity −74.9%. They feed the Quality Score of 55/100, which measures business quality independently of the share price.
How far is NRGN from its 52-week high?
Nrgene Technologies Ltd trades at 0.8300 ILA, about 72% below its 52-week high of 2.98 ILA and 2% above the low of 0.8120 ILA (as of Sep 30, 2026). Distance from the high says nothing about value: that is what the fair value of 1.17 ILA is for.
Which stocks are comparable to Nrgene Technologies Ltd?
From the same area (Technology) we also value SAP SE, Salesforce, Inc, Shopify Inc, ServiceNow, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nrgene Technologies Ltd stock attractive at the current price?
The data as of Oct 4, 2026: price 0.8300 ILA, calculated fair value 1.17 ILA (+41%), Quality Score 55/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NRGN calculated?
We run Nrgene Technologies Ltd through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 1.17 ILA, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. Nrgene Technologies Ltd currently trades 29 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Nrgene Technologies Ltd (NRGN)?
The closing price on Sep 30, 2026 was 0.8300 ILA. Our model-based fair value is 1.17 ILA, about +41% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Nrgene Technologies Ltd right now?
The price is below even our cautious bear case (1.11 ILA). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (55/100) at a price below fair value, the discount is the argument here, not the business quality. The models converge in a tight band (1.11 ILA to 1.25 ILA), unusually little disagreement for a valuation.
Key figures of Nrgene Technologies Ltd
How large is the market capitalisation of Nrgene Technologies Ltd (NRGN)?
The market capitalisation of Nrgene Technologies Ltd is 10.9M ILA. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Nrgene Technologies Ltd (NRGN)?
The price-to-sales ratio of Nrgene Technologies Ltd is 3.76 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Nrgene Technologies Ltd (NRGN)?
Earnings per share at Nrgene Technologies Ltd are −0.3400 ILA. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Nrgene Technologies Ltd (NRGN)?
The net margin of Nrgene Technologies Ltd is −47.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Nrgene Technologies Ltd (NRGN)?
The return on equity (ROE) of Nrgene Technologies Ltd is −74.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nrgene Technologies Ltd (NRGN)?
On an EBIT basis the return on assets of Nrgene Technologies Ltd is −36.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nrgene Technologies Ltd (NRGN)?
The operating margin of Nrgene Technologies Ltd is −537% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nrgene Technologies Ltd (NRGN)?
Revenue at Nrgene Technologies Ltd is growing −38.0% versus a year earlier (3y avg +0.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net cash does Nrgene Technologies Ltd (NRGN) hold?
Nrgene Technologies Ltd holds more cash than debt, $4.0M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Nrgene Technologies Ltd in the live analysis
One click puts Nrgene Technologies Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
